Abcam reveals new cell engineering facility in Bay Area
– State-of-the-art site will enable rapid delivery of engineered cell lines – Powering ready-to-use edited cell-line portfolio expansion – Enable comprehensive customization for research, diagnostic and therapeutic development Today Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life science reagents and tools, announced the opening of a new 16,000 sq ft purpose-fitted facility in Fremont, CA, which will serve as a…
